Autopsy report · NCT01836549
Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
Cause of deathOther
“Due to several intracranial hemorrhages and recommendation by the PBTC DSMB.”
Life of this trial
- Registered 1 month after it had already started.
- Ran for about 3 years 1 month before it stopped.
- 43 participants enrolled.
- Results were posted on the registry 2 years 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Pediatric Brain Tumor Consortium
- Sponsor type
- University, hospital or other
- Conditions
- Anaplastic Astrocytoma; Anaplastic Ependymoma; Astrocytoma, Grade II; Ependymoma; Giant Cell Glioblastoma; Glioblastoma
- Interventions
- imetelstat sodium
- Participants
- 43
- Sites
- 11
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.